← FDA Drug Approvals (Drugs@FDA)

KISUNLA

BLA · Biologics License Application · Sponsor: ELI LILLY CO · Approved 2024-07-02

Drug application

FDA Application #
BLA761248
Application type
Biologics License Application
Brand name
KISUNLA
Generic name
DONANEMAB-AZBT
Active ingredients
DONANEMAB-AZBT
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Prescription
Sponsor
ELI LILLY CO
Manufacturer
Eli Lilly and Company
First approval
2024-07-02

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown